The use of oclacitinib compared to azathioprine in the management of canine pemphigus foliaceus: A retrospective analysis.

Background: Oclacitinib (Apoquel; Zoetis) has been reported to be beneficial for treating immune-mediated disorders.

Hypothesis/objectives: This retrospective study evaluates in which group of dogs [oclacitinib (OC) or azathioprine (AZ)] remission of pemphigus foliaceus (PF) was more effectively achieved with matched induction dosing of glucocorticoids; it further evaluates which group had a higher glucocorticoid-sparing effect.

Animals: Review of 30 medical records of dogs diagnosed with PF presented to a private practice dermatological service.